Lionel Fry
Research Subjects
Lionel Fry has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Barbara S. Baker
The Haven London UK
6 shared publicationsAnne V. Powles
Department of Medicine Imperial College London UK
4 shared publicationsAnne Powles
Imperial College
3 shared publicationsLars Engstrand
Department of Life Sciences Karolinska Institute Solna Sweden
2 shared publications- Shlomo Sela (Saldinger)
Department of Food Science, Institute for Postharvest and Food Science, The Volcani Institute, Agriculture Research Organization, Rishon LeZion, Israel
2 shared publications A Powles
Department of Dermatology, Faculty of Medicine, St Mary's campus, Imperial College, London, UK
1 shared publication
Latest Publications
- 18 November 2014
- Published by Wiley in Experimental Dermatology
- Vol. 24 (4) , 241-244
Psoriasis is not an autoimmune disease?
The concept that psoriasis is an autoimmune disease needs to be questioned. The autoimmune label has been based on molecular mimicry between streptococcal and keratin proteins and the existence of homologous peptides between these proteins. However, it is only peripheral blood CD8, and not CD4, T lymphocytes that respond to the homologous peptides. This ignores the fact that it is CD4 T cells which are necessary to initiate psoriasis. Recent studies on skin bacterial microbiota have found a variety of bacteria in both normal skin and psoriatic lesions. In biopsy specimens, the most common phylum was Firmicutes and the most common genus streptococcus in both psoriasis and normal skin. The innate immune system is activated in psoriasis, and recent genetic findings have shown the majority of susceptibility loci are associated with innate immunity. There is a known clinical relationship between both Crohn's disease (CD) and periodontitis, and psoriasis, and patients with psoriasis share mutations in some innate immunity genes with individuals with CD. It is now accepted that CD is due to a breakdown of immune tolerance (dysbiosis) to bacteria in the intestine. These findings suggest that psoriasis is initiated by an abnormal response to bacteria in the skin due to genetic factors.
- 18 November 2014
- Published by Wiley in Experimental Dermatology
- Vol. 24 (4) , 241-244
Psoriasis is not an autoimmune disease?
The concept that psoriasis is an autoimmune disease needs to be questioned. The autoimmune label has been based on molecular mimicry between streptococcal and keratin proteins and the existence of homologous peptides between these proteins. However, it is only peripheral blood CD8, and not CD4, T lymphocytes that respond to the homologous peptides. This ignores the fact that it is CD4 T cells which are necessary to initiate psoriasis. Recent studies on skin bacterial microbiota have found a variety of bacteria in both normal skin and psoriatic lesions. In biopsy specimens, the most common phylum was Firmicutes and the most common genus streptococcus in both psoriasis and normal skin. The innate immune system is activated in psoriasis, and recent genetic findings have shown the majority of susceptibility loci are associated with innate immunity. There is a known clinical relationship between both Crohn's disease (CD) and periodontitis, and psoriasis, and patients with psoriasis share mutations in some innate immunity genes with individuals with CD. It is now accepted that CD is due to a breakdown of immune tolerance (dysbiosis) to bacteria in the intestine. These findings suggest that psoriasis is initiated by an abnormal response to bacteria in the skin due to genetic factors.
- 8 July 2013
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 169 (1) , 47-52
Is chronic plaque psoriasis triggered by microbiota in the skin?
There is a known association between psoriasis and Crohn disease (CD). Patients with CD are five times more likely to develop psoriasis, and, conversely, patients with psoriasis are more likely to develop CD. Many gastroenterologists now accept that CD results from a breakdown of immune tolerance to the microbiota of the intestine in genetically susceptible individuals. The microbiota of the skin have recently been investigated in psoriasis. Firmicutes was the most common phylum, and Streptococcus the most common genus identified. Beta-haemolytic streptococci have been implicated in both guttate and chronic plaque psoriasis. Furthermore, the innate immune system has been shown to be activated in psoriasis, and many of the genes associated with the disease are concerned with the signalling pathways of the innate immune system, notably interleukin-23 and nuclear factor κB. Patients with psoriasis also have an increased incidence of periodontitis, a disease thought to be due to an abnormal response to normal oral commensals. Based on the similarities between CD and psoriasis, we propose that psoriasis is due to a breakdown of immune tolerance to the microbiota of the skin. In support of this hypothesis we provide evidence for microbiota in the skin, activation of the innate immune system, and genetic abnormalities involving the innate immune system.
- 8 July 2013
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 169 (1) , 47-52
Is chronic plaque psoriasis triggered by microbiota in the skin?
There is a known association between psoriasis and Crohn disease (CD). Patients with CD are five times more likely to develop psoriasis, and, conversely, patients with psoriasis are more likely to develop CD. Many gastroenterologists now accept that CD results from a breakdown of immune tolerance to the microbiota of the intestine in genetically susceptible individuals. The microbiota of the skin have recently been investigated in psoriasis. Firmicutes was the most common phylum, and Streptococcus the most common genus identified. Beta-haemolytic streptococci have been implicated in both guttate and chronic plaque psoriasis. Furthermore, the innate immune system has been shown to be activated in psoriasis, and many of the genes associated with the disease are concerned with the signalling pathways of the innate immune system, notably interleukin-23 and nuclear factor κB. Patients with psoriasis also have an increased incidence of periodontitis, a disease thought to be due to an abnormal response to normal oral commensals. Based on the similarities between CD and psoriasis, we propose that psoriasis is due to a breakdown of immune tolerance to the microbiota of the skin. In support of this hypothesis we provide evidence for microbiota in the skin, activation of the innate immune system, and genetic abnormalities involving the innate immune system.
- 8 November 2011
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 304 (1) , 15-22
Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin
Microorganisms have been implicated in the pathogenesis of psoriasis. Previous studies of psoriasis and normal skin have used swabs from the surface rather than skin biopsies. In this study, biopsies were taken from 10 patients with psoriasis and 12 control subjects from unmatched sites. Samples were analysed with massive parallel pyrosequencing on the 454 platform targeting the 16S rRNA gene and the variable regions V3–V4. The samples grouped into 19 phyla, 265 taxon and 652 operational units (OTUs) at 97% identity. A cut-off abundance level was set at 1%. The three most common phyla in both normal and psoriasis skin were Firmicutes (39% psoriasis, 43% normal skin), Proteobacteria (38% psoriasis, 27% normal skin) and Actinobacteria (5% psoriasis, 16% normal skin, p = 0.034). In trunk skin, Proteobacteria were present at significantly higher levels in psoriasis compared to controls (52 vs. 32%, p = 0.0113). The commonest genera were Streptococci in both psoriasis (32%) and normal skin (26%). Staphylococci were less common in psoriasis (5%) than in controls (16%), as were Propionibacteria (psoriasis 0.0001669%, controls 0.0254%). Both Staphylococci and Propionibacteria were significantly lower in psoriasis versus control limb skin (p = 0.051, 0.046, respectively). This study has shown some differences in microbiota between psoriasis and normal skin. Whether these are of primary aetiological significance, or secondary to the altered skin of psoriasis remains to be determined.
- 8 November 2011
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 304 (1) , 15-22
Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin
Microorganisms have been implicated in the pathogenesis of psoriasis. Previous studies of psoriasis and normal skin have used swabs from the surface rather than skin biopsies. In this study, biopsies were taken from 10 patients with psoriasis and 12 control subjects from unmatched sites. Samples were analysed with massive parallel pyrosequencing on the 454 platform targeting the 16S rRNA gene and the variable regions V3–V4. The samples grouped into 19 phyla, 265 taxon and 652 operational units (OTUs) at 97% identity. A cut-off abundance level was set at 1%. The three most common phyla in both normal and psoriasis skin were Firmicutes (39% psoriasis, 43% normal skin), Proteobacteria (38% psoriasis, 27% normal skin) and Actinobacteria (5% psoriasis, 16% normal skin, p = 0.034). In trunk skin, Proteobacteria were present at significantly higher levels in psoriasis compared to controls (52 vs. 32%, p = 0.0113). The commonest genera were Streptococci in both psoriasis (32%) and normal skin (26%). Staphylococci were less common in psoriasis (5%) than in controls (16%), as were Propionibacteria (psoriasis 0.0001669%, controls 0.0254%). Both Staphylococci and Propionibacteria were significantly lower in psoriasis versus control limb skin (p = 0.051, 0.046, respectively). This study has shown some differences in microbiota between psoriasis and normal skin. Whether these are of primary aetiological significance, or secondary to the altered skin of psoriasis remains to be determined.
- 4 July 2010
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 302 (7) , 495-498
Evidence for the presence of bacteria in the blood of psoriasis patients
Evidence exists that microorganisms, particularly in the throat and skin, play a role in the pathogenesis of psoriasis. The aim of this study was to investigate whether evidence for the presence of bacteria, including Streptococcus pyogenes, can be demonstrated in the peripheral blood of patients with guttate and/or chronic plaque psoriasis. Peripheral blood samples from 20 patients with psoriasis, seven guttate, six chronic plaque and seven chronic plaque with associated guttate flare and from 16 control subjects were studied for the presence of bacteria by PCR using universal 16S ribosomal DNA primers and specific primers for S. pyogenes. Sequence analysis of amplified 16S rRNA sequences was used to determine taxonomic identity. Ribosomal bacterial DNA was detected in the blood of all 20 patients with psoriasis, but in none of the controls. Streptococci were detected in six of seven patients with guttate psoriasis, but none had staphylococci. In contrast, staphylococci were identified in 9 of 13 patients with chronic plaque psoriasis, whilst only 2 demonstrated streptococci. In three psoriasis patients, species other than streptococci and staphylococci were identified. These findings suggest that psoriasis is associated with bacteraemia, with distinct taxonomic groups present in guttate and chronic plaque psoriatic subtypes. The causes of the bacteraemia and its implications in psoriasis have yet to be determined.
- 4 July 2010
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 302 (7) , 495-498
Evidence for the presence of bacteria in the blood of psoriasis patients
Evidence exists that microorganisms, particularly in the throat and skin, play a role in the pathogenesis of psoriasis. The aim of this study was to investigate whether evidence for the presence of bacteria, including Streptococcus pyogenes, can be demonstrated in the peripheral blood of patients with guttate and/or chronic plaque psoriasis. Peripheral blood samples from 20 patients with psoriasis, seven guttate, six chronic plaque and seven chronic plaque with associated guttate flare and from 16 control subjects were studied for the presence of bacteria by PCR using universal 16S ribosomal DNA primers and specific primers for S. pyogenes. Sequence analysis of amplified 16S rRNA sequences was used to determine taxonomic identity. Ribosomal bacterial DNA was detected in the blood of all 20 patients with psoriasis, but in none of the controls. Streptococci were detected in six of seven patients with guttate psoriasis, but none had staphylococci. In contrast, staphylococci were identified in 9 of 13 patients with chronic plaque psoriasis, whilst only 2 demonstrated streptococci. In three psoriasis patients, species other than streptococci and staphylococci were identified. These findings suggest that psoriasis is associated with bacteraemia, with distinct taxonomic groups present in guttate and chronic plaque psoriatic subtypes. The causes of the bacteraemia and its implications in psoriasis have yet to be determined.
- 22 July 2008
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 300 (8) , 441-449
An investigation of antistreptococcal antibody responses in guttate psoriasis
- 22 July 2008
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 300 (8) , 441-449
An investigation of antistreptococcal antibody responses in guttate psoriasis
- Top Cited Papers
- 1 November 2007
- Published by Elsevier in Clinics in Dermatology
- Vol. 25 (6) , 606-615
Triggering psoriasis: the role of infections and medications
- 1 November 2007
- Published by Elsevier in Clinics in Dermatology
- Vol. 25 (6) , 606-615
Top Cited PapersTriggering psoriasis: the role of infections and medications
- Open Access
- 30 April 2007
- Published by Elsevier in Autoimmunity Reviews
- Vol. 6 (5) , 286-289
Psoriasis — A possible candidate for vaccination
- 30 April 2007
- Published by Elsevier in Autoimmunity Reviews
- Vol. 6 (5) , 286-289
Open AccessPsoriasis — A possible candidate for vaccination
- 21 February 2006
- Published by Wiley in The Journal of Pathology
- Vol. 209 (2) , 174-181
Peptidoglycan and peptidoglycan‐specific Th1 cells in psoriatic skin lesions
We have previously demonstrated, in psoriatic skin lesions, the presence of a subset of dermal CD4+ T cells that produce interferon‐γ (IFN‐γ) in response to a mixture of cell wall proteins extracted from group A streptococci. However, the identity of the antigen(s) involved is unknown. To investigate the hypothesis that peptidoglycan (PG), the major constituent of the streptococcal cell wall, acts as a T cell activator in psoriasis, we performed in situ analysis to detect antigen‐presenting cells containing PG in lesional versus non‐lesional skin, and determined proliferation and IFN‐γ responses of lesional skin T cells. Increased numbers of PG‐containing cells were detected in the dermal papillae and cellular infiltrates of guttate and chronic plaque skin lesions compared with normal and non‐lesional psoriatic skin. A varying proportion of these were CD68+ macrophages, but the remaining cells did not double stain for either Langerhans' or dendritic cell markers. Psoriatic dermal streptococcal‐specific CD4+ T cell lines proliferated and produced IFN‐γ in a self HLA‐DR allele‐restricted manner in response to streptococcal PG, excluding mitogenic or superantigenic stimulation, but were unresponsive to staphylococcal PG. Similarly, psoriatic staphylococcus‐specific T cell lines recognized staphylococcal, but not streptococcal, PG by IFN‐γ production. The presence of PG‐containing macrophages in close association with PG‐specific CD4+ T cells in lesional skin suggests that PG may be responsible, at least in part, for T cell activation in psoriasis. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
- 21 February 2006
- Published by Wiley in The Journal of Pathology
- Vol. 209 (2) , 174-181
Peptidoglycan and peptidoglycan‐specific Th1 cells in psoriatic skin lesions
We have previously demonstrated, in psoriatic skin lesions, the presence of a subset of dermal CD4+ T cells that produce interferon‐γ (IFN‐γ) in response to a mixture of cell wall proteins extracted from group A streptococci. However, the identity of the antigen(s) involved is unknown. To investigate the hypothesis that peptidoglycan (PG), the major constituent of the streptococcal cell wall, acts as a T cell activator in psoriasis, we performed in situ analysis to detect antigen‐presenting cells containing PG in lesional versus non‐lesional skin, and determined proliferation and IFN‐γ responses of lesional skin T cells. Increased numbers of PG‐containing cells were detected in the dermal papillae and cellular infiltrates of guttate and chronic plaque skin lesions compared with normal and non‐lesional psoriatic skin. A varying proportion of these were CD68+ macrophages, but the remaining cells did not double stain for either Langerhans' or dendritic cell markers. Psoriatic dermal streptococcal‐specific CD4+ T cell lines proliferated and produced IFN‐γ in a self HLA‐DR allele‐restricted manner in response to streptococcal PG, excluding mitogenic or superantigenic stimulation, but were unresponsive to staphylococcal PG. Similarly, psoriatic staphylococcus‐specific T cell lines recognized staphylococcal, but not streptococcal, PG by IFN‐γ production. The presence of PG‐containing macrophages in close association with PG‐specific CD4+ T cells in lesional skin suggests that PG may be responsible, at least in part, for T cell activation in psoriasis. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
- Open Access
- 1 January 2000
- Published by Wiley in Journal of Immunology Research
- Vol. 13 (2-4) , 361-367
Psoriasis—a Possible Candidate for Vaccination
- 1 January 2000
- Published by Wiley in Journal of Immunology Research
- Vol. 13 (2-4) , 361-367
Open AccessPsoriasis—a Possible Candidate for Vaccination
- 31 March 1998
- Published by Elsevier in Journal of Dermatological Science
- Vol. 16, S172
T cell response to streptococcal M protein in psoriasis
- 31 March 1998
- Published by Elsevier in Journal of Dermatological Science
- Vol. 16, S172
T cell response to streptococcal M protein in psoriasis